Endocrinology News and Research

Latest Endocrinology News and Research

Scientists demonstrate how glowing fish can help screen drugs that control metabolic disorders

A tiny, translucent zebrafish that glows green when its liver makes glucose has helped an international team of researchers identify a compound that regulates whole-body metabolism and appears to protect obese mice from signs of metabolic disorders.

2 Dec 2012

Men should see a doctor and be proactive about their health, say UAB experts

Experts at the University of Alabama at Birmingham (UAB) say a man's tendency to wait until the onset of sickness to see his doctor is a major detriment to health because key screenings are missed.

1 Dec 2012

Retail clinics could undermine primary care patient-physician relationships

Using retail walk-in health clinics, often located inside pharmacies or big-box stores, for simple acute care problems can interfere with establishing and maintaining a relationship with a primary care provider, finds a new study in the Journal of General Internal Medicine.

1 Dec 2012

Collaborative care significantly improves depression and anxiety outcomes

Collaborative care, a model that involves multiple clinicians working with a patient, significantly improves depression and anxiety outcomes compared to standard primary care treatment for up to two years, finds a new review by The Cochrane Library.

1 Dec 2012

NCQA accredits Jefferson Medical Care - South Philadelphia as Patient-Centered Medical Home

Jefferson Medical Care - South Philadelphia, a primary care practice, has received accreditation from the National Committee for Quality Assurance (NCQA) as a Patient-Centered Medical Home, showing its commitment to evidence-based, patient-centered care that focuses on coordinated and long-term collaborative patient-physician partnerships.

1 Dec 2012

New study on mice could open door to methods of regulating cell proliferation in humans

A newly-engineered strain of mice whose dividing cells express a fluorescent protein could open the door to new methods of regulating cell proliferation in humans.

1 Dec 2012

Tissue damage, disease severity in C. diff. infection associated with disruption of PPARγ pathway

Researchers in the Nutritional Immunology and Molecular Medicine Laboratory at Virginia Bioinformatics Institute have discovered how a common diarrhea-causing bacterium sends the body's natural defenses into overdrive, actually intensifying illness while fighting infection.

1 Dec 2012

Study of hospital-acquired infection yields potential therapeutic target

30 Nov 2012

Air quality in cities linked to inflammatory risk in diabetes

Exposure to traffic-related air pollutants is associated with a rapid increase in systemic inflammation in patients with diabetes, report Indian researchers.

30 Nov 2012

Topical simvastatin may be answer to nonhealing diabetic wounds

Topical simvastatin significantly accelerates wound healing in mice and may be a good treatment option for diabetic patients with nonhealing wounds, say researchers.

30 Nov 2012

Research examines tumor-initiating events that lead to pancreatic cancer

A diagnosis of pancreatic cancer is particularly devastating since the prognosis for recovery is usually poor, with the cancer most often not detected until late stages.

30 Nov 2012

Diabetes education critical for uncontrolled high blood sugar people with cancer

When people with Type 2 diabetes are diagnosed with cancer -- a disease for which they are at higher risk -- they ignore their diabetes care to focus on cancer treatment, according to new Northwestern Medicine- research. But uncontrolled high blood sugar is more likely to kill them and impairs their immune system's ability to fight cancer.

30 Nov 2012

Viewpoints: GOP attack on Medicare, Medicaid could hurt critical programs; Will says Obama is repeating his overreach on health care

Congressional Republicans are insisting that big cuts to Medicare and Medicaid be on the table in the negotiations over the so-called fiscal cliff and deficit reduction. That stance is largely a political move against two programs, which have been critical to the public welfare for the past half-century.

30 Nov 2012

Hospital developments: Calif. hospital chain fined in privacy case; Ore. officials say hospitals not overcharged on provider tax

Details on how hospitals around the nation are making deals, and getting fined, graded or taxed in this roundup.

30 Nov 2012

Roundup: Conn. health care programs face $70M cut; Miss. abortion clinic again asks judge to block law that could force it to close

Connecticut's social services safety net and its public colleges and universities took the brunt Wednesday of Gov. Dannel P. Malloy's first effort to whittle down a $363 million state budget deficit.

30 Nov 2012

African Americans experience faster progression of CKD during later stages

Among individuals with chronic kidney disease (CKD), African Americans experience faster progression of the disease during later stages compared with other races, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

30 Nov 2012

U.K. NICE issues final draft guidance on Alimera Sciences’ ILUVIEN

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) has issued final draft guidance indicating that ILUVIEN is not recommended for the treatment of chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.

30 Nov 2012

FDA clears NeuroMetrix’s SENSUS Pain Management System

NeuroMetrix, Inc., a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the disposable electrode that is used in conjunction with its SENSUS device.

30 Nov 2012

Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer

Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved COMETRIQ (cabozantinib) for the treatment of progressive, metastatic medullary thyroid cancer (MTC).

30 Nov 2012

European Medicines Agency accepts Exelixis’ COMETRIQ MAA for review

Exelixis, Inc. today announced the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for COMETRIQ (cabozantinib) for the proposed indication of treatment of progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer (MTC).

29 Nov 2012

Endocrinology News and Research

Latest Endocrinology News and Research

Scientists demonstrate how glowing fish can help screen drugs that control metabolic disorders

Men should see a doctor and be proactive about their health, say UAB experts

Retail clinics could undermine primary care patient-physician relationships

Collaborative care significantly improves depression and anxiety outcomes

NCQA accredits Jefferson Medical Care - South Philadelphia as Patient-Centered Medical Home

New study on mice could open door to methods of regulating cell proliferation in humans

Tissue damage, disease severity in C. diff. infection associated with disruption of PPARγ pathway

Study of hospital-acquired infection yields potential therapeutic target

Air quality in cities linked to inflammatory risk in diabetes

Topical simvastatin may be answer to nonhealing diabetic wounds

Research examines tumor-initiating events that lead to pancreatic cancer

Diabetes education critical for uncontrolled high blood sugar people with cancer

Viewpoints: GOP attack on Medicare, Medicaid could hurt critical programs; Will says Obama is repeating his overreach on health care

Hospital developments: Calif. hospital chain fined in privacy case; Ore. officials say hospitals not overcharged on provider tax

Roundup: Conn. health care programs face $70M cut; Miss. abortion clinic again asks judge to block law that could force it to close

African Americans experience faster progression of CKD during later stages

U.K. NICE issues final draft guidance on Alimera Sciences’ ILUVIEN

FDA clears NeuroMetrix’s SENSUS Pain Management System

Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer

European Medicines Agency accepts Exelixis’ COMETRIQ MAA for review

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Endocrinology News and Research

Latest Endocrinology News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in